Results 131 to 140 of about 210,676 (190)

Study of Molecular Genetic Characteristics of Influenza A(H1N1) Viruses Identified During Monitoring in Kazakhstan (2023-2026). [PDF]

Viruses
Klivleyeva N, Glebova T, Baimukhametova A, Karamendin K, Saktaganov N, Ongarbayeva N, Kalkozhayeva M, Ibragimova I, Mutaliyeva A, Gabiden A, Webby R.   +10 more
europepmc   +1 more source

Influenza A/H3N2 epidemiology in England during the 2025 to 2026 season: a mathematical modelling study. [PDF]

Commun Health
Hay JA, Alahakoon P, Greenshields-Watson A, Kendall M, Ghafari M, Wymant C, Hinch R, Ferretti L, Panovska-Griffiths J, Fraser C.   +9 more
europepmc   +1 more source

Molecular Epidemiology and Evolution of Swine Influenza A Viruses, Vietnam, 2020-2024. [PDF]

Emerg Infect Dis
Bui NA, Song ZY, Cheng SMS, Dao DT, Chang LDJ, Liu GYZ, Nguyen QH, Dang TH, Nguyen QH, Woo TLY, Chan CHC, Lam TTY, Bui VN, Peiris M.   +13 more
europepmc   +1 more source

Epidemiology, temporal trends and co-infection of 13 respiratory pathogens in 32,125 children: a 3-year retrospective study. [PDF]

Front Pediatr
Zhang Y, Wang S, Huang X.
europepmc   +1 more source

Efficient Production of Swine Influenza Virus Using Serum-Free Suspension MDCK Cells for Vaccine Manufacturing. [PDF]

J Microbiol Biotechnol
Koo SJ, Kim YG.
europepmc   +1 more source

Molecular Characterization of Influenza A(H3N2) Hemagglutinin Variants Circulating in Western Mexico, 2022. [PDF]

Int J Mol Sci
Hernandez-Gonzalez KM, Carranza-Aranda AS, Muñoz-Valle JF, Muñoz-Miranda LA, Vega-Magaña AN, Pereira-Suárez AL, Nava-Valdivia CA.   +6 more
europepmc   +1 more source

Elicitation of Potent H5N1- and H7N9-Neutralizing Antibody Responses in Rhesus Macaques by Sequential Heterologous Vaccination with mRNA and Adenoviral Vectors Encoding Full-Length Hemagglutinins. [PDF]

Viruses
Rosen BC, Mauter JT, Voigt TB, de Figueiredo Godoy G, Walker EL, Louw JJ, Ghosh N, Panayiotou C, Yrizarry-Medina A, Terao J, Rakasz EG, Reynolds MR, Dudley DM, Reed DS, Watkins DI, Ricciardi MJ.   +15 more
europepmc   +1 more source

Intranasal delivery of a COBRA-based protein vaccine adjuvanted with c-di-AMP enhances breadth of protective immune responses against seasonal influenza viruses. [PDF]

Front Immunol
Caetano CCS, Prots DA, Thomas MH, Micallef DR, Richardson RA, Ross TM.   +5 more
europepmc   +1 more source